Prevalence of hepatitis B and delta according to HIV-type: a multi-country cross-sectional survey in West Africa - Wikidata - awgldk - TriplyDB

Prevalence of hepatitis B and delta according to HIV-type: a multi-country cross-sectional survey in West Africa

Prevalence of hepatitis B and delta according to HIV-type: a multi-country cross-sectional survey in West Africa

http://www.wikidata.org/entity/Q33869423

about

High prevalence of hepatitis B infections in Burkina Faso (1996-2017): a systematic review with meta-analysis of epidemiological studies.

P2860

Q53689030-1317E21E-FDCE-44C5-A13C-C177D58106B2

P2860

Prevalence of hepatitis B and delta according to HIV-type: a multi-country cross-sectional survey in West Africa

http://www.wikidata.org/entity/Q33869423

description

2017 nî lūn-bûn

@nan

2017 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Prevalence of hepatitis B and ...... ectional survey in West Africa

@ast

Prevalence of hepatitis B and ...... ectional survey in West Africa

@en

type

label

Prevalence of hepatitis B and ...... ectional survey in West Africa

@ast

Prevalence of hepatitis B and ...... ectional survey in West Africa

@en

prefLabel

Prevalence of hepatitis B and ...... ectional survey in West Africa

@ast

Prevalence of hepatitis B and ...... ectional survey in West Africa

@en

P1433

Q33869423-DF59671F-E96A-4FC6-B751-E0A325909E02

P1476

Q33869423-B807E93F-2712-4F54-9F57-BC1D158EF092

P2093

Q33869423-0AF7C957-9B36-4D96-972D-C0B928A71130

Q33869423-3790ED7F-A464-4ABE-B3FB-3BF7D5D2280C

Q33869423-3C67E9F1-CE13-4AF5-8178-118A6FD6CEAB

Q33869423-632C8895-95AE-4713-8385-97E8C6538407

Q33869423-78501916-7B8A-4150-8404-EDAECAA8C197

Q33869423-DB58D469-90A5-478D-A092-F8E4180BFB68

Q33869423-DDADEF40-7EC1-4801-AD1F-E86BA0B55B72

Q33869423-E332B94D-0A68-4EAB-BD0F-DCB4364D1C50

P2860

Q33869423-0374F468-BCB6-4F16-A250-1B9E9E71E1BF

Q33869423-042201A0-77C8-4632-A6FD-3C63438BB942

Q33869423-0710A089-82D2-4222-8F26-F98D0EBF2DF9

Q33869423-0F5754EB-B55A-40EC-9580-98FCD7965AD7

Q33869423-1292BAAC-F026-4BC5-BBCF-1D2F8474A52B

Q33869423-161B89DB-0207-4FA0-A015-714D33687188

Q33869423-1634D18F-E2E2-4B71-A245-233CAF29208A

Q33869423-1AF2EC75-83E9-4E6B-B884-2B77E571401A

Q33869423-1B2F9BB2-FD7B-4399-80C4-DE7C8E986732

Q33869423-1F79DD58-B179-4527-9491-DE2E06CC594A

P2888

Q33869423-48A7CECC-A0C3-4D9F-B168-844F6C76BF45

P304

Q33869423-8E6D403E-13D7-43A5-8EDF-937699A20493

P31

Q33869423-AC5D93F0-8063-4394-A8EA-22D45788B7A6

P356

Q33869423-DA387B16-7B2A-4A8D-A8E7-F6BF1AD3AD77

P433

Q33869423-9C7AC0D0-608C-4B65-AE94-701472930114

P478

Q33869423-33B126A7-1C8E-4AD9-AF40-1F623ECF005D

P50

Q33869423-A7ADA51C-0DBD-4892-858D-C863066C5108

Q33869423-E8C26B1A-5C81-4BCB-98F6-D66AF0E26F70

P577

Q33869423-3D048847-56CC-4E7A-A960-D9F77B019756

P6179

Q33869423-CBCB2178-94E5-49E0-996F-F25F931EC122

P698

Q33869423-440222A5-4FC8-4376-91A5-E8F7405782C7

P921

Q33869423-55B5ACE2-2B32-43D7-8570-6ED93B4D40E5

P932

Q33869423-A46EA63C-E569-4044-AC81-25479D29C904

P356

S12879-017-2568-5

P1433

BMC Infectious Diseases

P1476

Prevalence of hepatitis B and ...... ectional survey in West Africa

@en

P2093

Boris K Tchounga

http://www.w3.org/2001/XMLSchema#string

Daouda K Minta

http://www.w3.org/2001/XMLSchema#string

Didier K Ekouevi

http://www.w3.org/2001/XMLSchema#string

Gilles Wandeler

http://www.w3.org/2001/XMLSchema#string

Guillaume Bado

http://www.w3.org/2001/XMLSchema#string

Mathieu Kabran

http://www.w3.org/2001/XMLSchema#string

Patrick A Coffie

http://www.w3.org/2001/XMLSchema#string

Serge P Eholie

http://www.w3.org/2001/XMLSchema#string

P2860

Structure of HIV-2 reverse transcriptase at 2.35-A resolution and the mechanism of resistance to non-nucleoside inhibitors.

Prevalence of hepatitis B virus infection in Nigeria, 2000-2013: a systematic review and meta-analysis

Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients

Effect of tenofovir with and without interferon on hepatitis D virus replication in HIV-hepatitis B virus-hepatitis D virus-infected patients

Hepatitis B and Delta virus are prevalent but often subclinical co-infections among HIV infected patients in Guinea-Bissau, West Africa: a cross-sectional study

Re-testing and misclassification of HIV-2 and HIV-1&2 dually reactive patients among the HIV-2 cohort of the West African Database to evaluate AIDS collaboration

Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis.

Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects.

Suppression of HBV by tenofovir in HBV/HIV coinfected patients: a systematic review and meta-analysis

[Prevalence of hepatitis B in people infected with HIV in Parakou in Benin].

P2888

s12879-017-2568-5

P304

466

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12879-017-2568-5

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Geoffrey S. Gottlieb

François Dabis

P577

2017-07-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090274850

http://www.w3.org/2001/XMLSchema#string

P698

28676076

http://www.w3.org/2001/XMLSchema#string

P921

Afelika ya Lumonso

P932

5496401

http://www.w3.org/2001/XMLSchema#string